Fiduciary Trust Co. cut its position in Aflac Incorporated (NYSE:AFL) by 3.0% during the first quarter, Holdings Channel reports. The firm owned 26,368 shares of the financial services provider’s stock after selling 825 shares during the period. Fiduciary Trust Co.’s holdings in Aflac were worth $1,910,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Regentatlantic Capital LLC increased its stake in Aflac by 16.3% in the first quarter. Regentatlantic Capital LLC now owns 23,685 shares of the financial services provider’s stock worth $1,715,000 after buying an additional 3,320 shares during the period. Quadrant Capital Group LLC increased its stake in Aflac by 0.3% in the first quarter. Quadrant Capital Group LLC now owns 2,391 shares of the financial services provider’s stock worth $166,000 after buying an additional 7 shares during the period. Gulf International Bank UK Ltd increased its stake in Aflac by 1.2% in the first quarter. Gulf International Bank UK Ltd now owns 127,539 shares of the financial services provider’s stock worth $9,236,000 after buying an additional 1,500 shares during the period. Weaver C. Barksdale & Associates Inc. increased its stake in Aflac by 50.4% in the first quarter. Weaver C. Barksdale & Associates Inc. now owns 21,405 shares of the financial services provider’s stock worth $1,550,000 after buying an additional 7,176 shares during the period. Finally, Denali Advisors LLC increased its stake in Aflac by 26.4% in the first quarter. Denali Advisors LLC now owns 198,349 shares of the financial services provider’s stock worth $14,364,000 after buying an additional 41,400 shares during the period. Hedge funds and other institutional investors own 64.13% of the company’s stock.

Aflac Incorporated (AFL) opened at 77.87 on Wednesday. The company has a market capitalization of $30.90 billion, a P/E ratio of 12.67 and a beta of 0.99. Aflac Incorporated has a one year low of $66.50 and a one year high of $79.86. The company’s 50-day moving average is $77.35 and its 200 day moving average is $73.42.

Aflac (NYSE:AFL) last released its quarterly earnings data on Thursday, April 27th. The financial services provider reported $1.67 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.05. Aflac had a net margin of 11.24% and a return on equity of 12.82%. The firm had revenue of $5.31 billion during the quarter, compared to analysts’ expectations of $5.40 billion. During the same period last year, the business earned $1.74 earnings per share. Aflac’s revenue was down 2.6% compared to the same quarter last year. On average, equities analysts anticipate that Aflac Incorporated will post $6.52 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and reposted in violation of U.S. and international trademark and copyright laws. The legal version of this report can be accessed at https://www.watchlistnews.com/fiduciary-trust-co-sells-825-shares-of-aflac-incorporated-nyseafl/1451596.html.

A number of research firms have recently weighed in on AFL. Bank of America Corporation upgraded shares of Aflac from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $75.00 to $78.00 in a report on Tuesday, July 4th. Barclays PLC boosted their target price on shares of Aflac from $71.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, July 3rd. Royal Bank Of Canada restated a “sell” rating and issued a $66.00 target price on shares of Aflac in a report on Wednesday, July 12th. FBR & Co restated a “market perform” rating and issued a $80.00 target price (up from $68.00) on shares of Aflac in a report on Wednesday, July 12th. Finally, Zacks Investment Research downgraded shares of Aflac from a “buy” rating to a “hold” rating in a report on Friday, July 7th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $75.54.

In related news, insider Paul S. Amos II sold 222,889 shares of the firm’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $77.40, for a total transaction of $17,251,608.60. Following the completion of the sale, the insider now directly owns 329,540 shares in the company, valued at $25,506,396. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Karole Lloyd acquired 1,000 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were purchased at an average price of $77.01 per share, with a total value of $77,010.00. Following the completion of the transaction, the director now owns 7,253 shares of the company’s stock, valued at approximately $558,553.53. The disclosure for this purchase can be found here. Over the last 90 days, insiders have sold 236,703 shares of company stock valued at $18,328,514. 3.00% of the stock is owned by company insiders.

About Aflac

Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company’s insurance business consists of two segments: Aflac Japan and Aflac U.S.

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.